<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03614754</url>
  </required_header>
  <id_info>
    <org_study_id>17/30/334</org_study_id>
    <nct_id>NCT03614754</nct_id>
  </id_info>
  <brief_title>Sacral Neuromodulation and Pudendal Somatic Afferents</brief_title>
  <official_title>The Involvement of Pudendal Somatic Afferents in Sacral Neuromodulation Assessed by Somatosensory Evoked Potentials of the Pudendal Nerve</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universiteit Antwerpen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universiteit Antwerpen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sacral neuromodulation is a well-excepted minimally invasive procedure for the treatment of
      overactive bladder and non-obstructive urinary retention.A tined lead with 4 stimulation
      electrodes is placed through the third or fourth sacral foramen and stimulates sacral roots
      in its vicinity. Since the sacral roots are mixed nerves, it is currently still unknown which
      nerve fibers are stimulated (autonomic vs somatic, afferent vs efferent) and what the
      mechanism of action is.

      This study examines the involvement of pudendal somatic afferents by measuring somatosensory
      evoked potentials elicited by stimulation of the pudendal nerve.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Anticipated">July 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Latency change</measure>
    <time_frame>3 weeks</time_frame>
    <description>Latency of somatosensory evoked potential are recorded before and after test procedure sacral neuromodulation expressed in milliseconds.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Overactive Bladder, Non Obstructive Urinary Retention</condition>
  <arm_group>
    <arm_group_label>Successes</arm_group_label>
    <description>Patients with reduction of symptoms &gt;50% during the test procedure for sacral neuromodulation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Failures</arm_group_label>
    <description>Patients with reduction of symptoms &lt;50% during the test procedure for sacral neuromodulation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Somatosensory evoked potentials</intervention_name>
    <description>Stimulation of the pudendal nerve while recording at the sensory cortex.</description>
    <arm_group_label>Failures</arm_group_label>
    <arm_group_label>Successes</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Urological patients with overactive bladder or non-obstructive urinary retention.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Overactive bladder

          -  Non-obstructive urinary retention

        Exclusion Criteria:

          -  Neurogenic disorders (e.g. cerebrovascular accident, spinal cord injury,...)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Donald A Vaganee, MD PhD student</last_name>
    <phone>8213047</phone>
    <phone_ext>323</phone_ext>
    <email>donald.vaganee@uantwerpen.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stefan De Wachter, MD PhD FEBU</last_name>
    <phone>8215934</phone>
    <phone_ext>323</phone_ext>
    <email>stefan.dewachter@uantwerpen.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Antwerp University Hospital</name>
      <address>
        <city>Edegem</city>
        <state>Antwerp</state>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan De Wachter, MD PhD FEABU</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>July 30, 2018</study_first_submitted>
  <study_first_submitted_qc>August 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 3, 2018</study_first_posted>
  <last_update_submitted>October 13, 2019</last_update_submitted>
  <last_update_submitted_qc>October 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universiteit Antwerpen</investigator_affiliation>
    <investigator_full_name>Donald Vagan√©e</investigator_full_name>
    <investigator_title>MD, PhD student</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder, Overactive</mesh_term>
    <mesh_term>Urinary Retention</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

